Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients

por Kortuem, K M, Braggio, E, Bruins, L, Barrio, S, Shi, C S, Zhu, Y X, Tibes, R, Viswanatha, D, Votruba, P, Ahmann, G, Fonseca, R, Jedlowski, P, Schlam, I, Kumar, S, Bergsagel, P L, Stewart, A K
Publicado 2016

MYC dysregulation in the progression of multiple myeloma

por Misund, K, Keane, N, Stein, CK, Asmann, YW, Day, G, Welsh, S, Wier, SV, Riggs, D, Ahmann, G, Chesi, M, Viswanatha, D, Kumar, SK, Dispenzieri, A, Gonzalez-Calle, V, Kyle, RA, O’Dwyer, M, Rajkumar, SV, Kortüm, KM, Keats, J, Fonseca, R, Stewart, AK, Kuehl, WM, Braggio, E, Bergsagel, PL
Publicado 2019

BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies

por Bogenberger, J M, Kornblau, S M, Pierceall, W E, Lena, R, Chow, D, Shi, C-X, Mantei, J, Ahmann, G, Gonzales, I M, Choudhary, A, Valdez, R, Camoriano, J, Fauble, V, Tiedemann, R E, Qiu, Y H, Coombes, K R, Cardone, M, Braggio, E, Yin, H, Azorsa, D O, Mesa, R A, Stewart, A K, Tibes, R
Publicado 2014